Evidence map›Paper›PMID 25678251›Full record

ArticleEuropean journal of pharmacology2015

Methamphetamine decreases CD4 T cell frequency and alters pro-inflammatory cytokine production in a model of drug abuse.

Mariana M Mata, T Celeste Napier, Steven M Graves, Fareeha Mahmood, Shohreh Raeisi, Linda L Baum

Open access · greenAbstract read
In one paragraph

Article in European journal of pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity.The Journal of pharmacology and experimental therapeutics · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mariana M MataDepartment of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, United States.
T Celeste NapierDepartment of Pharmacology and Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL 60612, United States.
Steven M GravesDepartment of Pharmacology and Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL 60612, United States.
Fareeha MahmoodDepartment of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, United States.
Shohreh RaeisiDepartment of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, United States.
Linda L BaumDepartment of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, United States. Electronic address: Linda_L_Baum@rush.edu.
Rush University Medical Center · USRush University · US

Funding

DevelopmentalP30AI082151 · NIAID · RUSH UNIVERSITY MEDICAL CENTER · PI CAFFREY, MICHAEL S. · 2009 to 2014
$4.6M
5-HT &Medication Development for Methamphetamine AbuseR01DA015760 · NIDA · RUSH UNIVERSITY MEDICAL CENTER · PI NAPIER, T. CELESTE · 2003 to 2007
$1.7M
5HT receptors, neuronal plasticity, and methamphetamine-induced place perference.F31DA024923 · NIDA · RUSH UNIVERSITY MEDICAL CENTER · PI GRAVES, STEVEN MICHAEL · 2009 to 2011
$108k
NIAID NIH HHS P30 AI082151NIDA NIH HHS DA015760NIDA NIH HHS DA024923NIDA NIH HHS F31 DA024923NIDA NIH HHS R01 DA015760
6 · The paper itself

Abstract

The reason co-morbid methamphetamine use and HIV infection lead to more rapid progression to AIDS is unclear. We used a model of methamphetamine self-administration to measure the effect of methamphetamine on the systemic immune system to better understand the co-morbidity of methamphetamine and HIV. Catheters were implanted into the jugular veins of male, Sprague Dawley rats so they could self-administer methamphetamine (n=18) or be given saline (control; n=16) for 14 days. One day after the last operant session, blood and spleens were collected. We measured serum levels of pro-inflammatory cytokines, intracellular IFN-γ and TNF-α, and frequencies of CD4(+), CD8(+), CD200(+) and CD11b/c(+) lymphocytes in the spleen. Rats that self-administered methamphetamine had a lower frequency of CD4(+) T cells, but more of these cells produced IFN-γ. Methamphetamine did not alter the frequency of TNF-α-producing CD4(+) T cells. Methamphetamine using rats had a higher frequency of CD8(+) T cells, but fewer of them produced TNF-α. CD11b/c and CD200 expression were unchanged. Serum cytokine levels of IFN-γ, TNF-α and IL-6 in methamphetamine rats were unchanged. Methamphetamine lifetime dose inversely correlated with serum TNF-α levels. Our data suggest that methamphetamine abuse may exacerbate HIV disease progression by activating CD4 T cells, making them more susceptible to HIV infection, and contributing to their premature demise. Methamphetamine may also increase susceptibility to HIV infection, explaining why men who have sex with men (MSM) and frequently use methamphetamine are at the highest risk of HIV infection.

Indexed as

AnimalsCD4-Positive T-LymphocytesCell CountCytokinesDisease Models, AnimalHumansInflammationIntracellular SpaceMaleMethamphetamineRatsRats, Sprague-DawleySelf AdministrationSpleenSubstance-Related DisordersCytokinesMethamphetamineCD4 T cellsInflammatory cytokinesMethamphetamineRatSelf-administration

Identifiers

PMID25678251
PMCPMC4396630
OpenAlexW2075258068

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.